Al18F-PSMA-617
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Al18F-PSMA-617, covering 2023-05-03 to 2023-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]